Navigation Links
Wonderful cheese is all in the culture
Date:1/6/2009

It's an age-old tradition that dates back at least 8,000 years but it seems we still have much to learn about the bacteria responsible for turning milk into cheese.

Now an international research team led by Newcastle University has identified a new line of bacteria they believe add flavour to some of the world's most exclusive cheeses.

The team used DNA fingerprinting techniques to identify eight previously undiscovered microbes on the French cheese Reblochon.

One of France's great mountain cheeses, Reblochon is a 'smear-ripened' cheese where the surface of the cheese is washed with a salt solution containing bacteria. This process helps to spread the bacteria across the surface of the cheese, ripening it from the outside in.

Other popular smear-ripened cheeses on the Christmas cheeseboard include Port de Salut, Livarot, Taleggio, Limburger and the Irish cheese Gubbeen.

The team have named the microbes Mycetocola reblochoni after the cheese they were first discovered in.

Project lead Professor Michael Goodfellow of Newcastle University said: "It has always been thought the bacteria cheese makers were putting in at the start of the process gave Reblochon its distinctive flavour.

"What our research actually showed was this new group of bacteria - the reblochoni were responsible for the ripening process, influencing the taste, texture and smell of the cheese."

Reblochon a soft, creamy, brie-like cheese is made in the Savoy mountain region of France.

Using samples from three different farmhouses, the team carried out a series of modern molecular techniques to classify the bacteria.

Traditionally, smear-ripened cheeses such as Reblochon are exposed to a starter culture, a live mixture containing the microbe Brevibacterium linens, to ripen the cheese.

Now the research has shown that a new group of bacterial strains are involved in the later stage of ripening, out-competing
'/>"/>

Contact: Louella Houldcroft
louella.houldcroft@ncl.ac.uk
44-191-222-5108
Newcastle University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Uncultured bacteria found in amniotic fluids of women who experience preterm births
2. Aquacultures growth seen as continuing
3. Nanotechnology culture war possible, says Yale study
4. UC Riverside rice geneticist receives high honor from US Department of Agriculture
5. Arid aquaculture among livelihoods promoted to relieve worsening pressure on worlds drylands
6. Cold Spring Harbor Protocols features organ and cell culture methods
7. Experiment demonstrates 110 years of sustainable agriculture
8. Reversible 3-D cell culture gel invented
9. Meeting the challenges of teaching agriculture
10. Plants in forest emit aspirin chemical to deal with stress; discovery may help agriculture
11. Study: Migrant laborers valuable to horticulture industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2015)... YORK , June 16, 2015  With the ... world, security remains a top concern. The recent compromise ... confirms the need for strong authentication within government agencies. ... Token, a biometric one-time password (OTP) authenticator, has been ... Standards (FIPS) 140-2 Level 3 validation for tamper proofing. ...
(Date:6/16/2015)... Fingerprint Cards (FPC) raises the revenue ... amount to at least 340 MSEK to that it will ... in market growth and orders received the revenue guidance for ... for 2015 will exceed 1,500 MSEK to an updated guidance ... Due to receipt of orders of touch fingerprint ...
(Date:6/15/2015)... NEW YORK , June 15, 2015 ... released today from Telstra reveals the majority of US consumers ... recognise them via biometrics, such as fingerprint and voiceprint, instead ... usernames. According to Telstra,s " Mobile Identity   ... " report, with smartphones now the primary channel ...
Breaking Biology News(10 mins):Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 4
... 26,2009) Autism Speaks, the nation,s largest autism science ... $5 million to investigate genetic and environmental risk factors ... two large-scale, multi-site studies focusing on a collaborative prospective ... with autism, who are at higher genetic risk for ...
... goat born without front legs learned to walk upright. ... Johnny Eck, a "half-man" born without legs, grew naturally ... twins Abigail and Brittany Hensel live successfully with separate heads ... arm, but they manage to drive, swim, shuffle cards and ...
... research has found that modern lifestyle habits may play a ... decay. A review of the scientific evidence over ... toothpaste, good oral hygiene and health education, may override the ... published online in a Supplement to the journal Obesity ...
Cached Biology News:Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 2Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 3Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 4Autism Speaks funds $5 million to studies on genetic and environmental risk factors for autism 5'Freaks' help scientist unravel nature and nurture 2'Freaks' help scientist unravel nature and nurture 3
(Date:7/6/2015)... ... July 06, 2015 , ... Proove Biosciences ... bi-annual Pain Management Medical Advisory Board meeting in Palm Springs, California. At the ... Development team to discuss new clinical practice and research ideas. The Board also ...
(Date:7/6/2015)... -- Viveve Medical, Inc. ("Viveve") (OTCQB: VIVMF), a company focused on women,s ... Executive Officer, and Scott Durbin , Viveve,s Chief Financial ... , , , DATE:    , , , ...     , , , 12:15 PM EDT , ...   ,    ...
(Date:7/3/2015)... 3, 2015 ... osoitteessa  http://www.openinnovationinscience.at Wienissä pidettävään ... Science" -jatkokoulutusohjelmaan 22.7.2015 asti.  ... tekemän, kansainvälisiä tutkijoita ja tiedemiehiä ... suurinta haastetta ovat kannustimien puute ...
(Date:7/3/2015)... July 3, 2015  Pomerantz LLP announces that a ... Inc. ("Puma" or the "Company")(NYSE: PBYI ) and ... United States District Court, Central District of ... behalf of a class consisting of all persons or ... and May 13, 2015 inclusive (the "Class Period").  This ...
Breaking Biology Technology:Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3Viveve to Webcast Live at VirtualInvestorConferences.com 2Viveve to Webcast Live at VirtualInvestorConferences.com 3Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 2SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 3SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI 4
... a cell-based clinical trial that may have far-reaching implications for future ... ... 29, 2008 -- Singapore has embarked on a cell-based clinical trial ... , , , ,The trial, currently ongoing, involves up to 35 ...
... 29, Rosetta Genomics Ltd. (Nasdaq: ROSG ), a ... its,management will present at Oppenheimer 19th Annual Healthcare ... Hotel in New York,City., About MicroRNA, ... that act as master regulators and have the ...
... 29 Inverness Medical,Innovations, Inc. (Amex: IMA ), ... its financial results for the quarter,ended September 30, 2008., ... recorded net revenue of,$438.8 million compared to net revenue ... revenue increase was primarily due to $118.7 million,of incremental ...
Cached Biology Technology:Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer 2Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer 3Singapore Medicine - Breakthrough Development of Cell Therapy Treatment for Cancer 4Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 2Rosetta Genomics to Present at Oppenheimer's 19th Annual Healthcare Conference 3Inverness Medical Innovations Announces Third Quarter 2008 Results 2Inverness Medical Innovations Announces Third Quarter 2008 Results 3Inverness Medical Innovations Announces Third Quarter 2008 Results 4Inverness Medical Innovations Announces Third Quarter 2008 Results 5Inverness Medical Innovations Announces Third Quarter 2008 Results 6Inverness Medical Innovations Announces Third Quarter 2008 Results 7Inverness Medical Innovations Announces Third Quarter 2008 Results 8Inverness Medical Innovations Announces Third Quarter 2008 Results 9Inverness Medical Innovations Announces Third Quarter 2008 Results 10Inverness Medical Innovations Announces Third Quarter 2008 Results 11Inverness Medical Innovations Announces Third Quarter 2008 Results 12Inverness Medical Innovations Announces Third Quarter 2008 Results 13Inverness Medical Innovations Announces Third Quarter 2008 Results 14Inverness Medical Innovations Announces Third Quarter 2008 Results 15Inverness Medical Innovations Announces Third Quarter 2008 Results 16
CMRL Medium-1066 (1X) liquid...
... 11(R)-HETE is biosynthesized by the 11(R)-LOs ... and the fresh water hydra, H. ... relates to oocyte maturation and tentacle ... is also produced when aspirin-treated recombinant ...
... The PhosphatidylEthanolamine-Binding Protein (PEBP) does ... serine protease inhibitors. PEBP is ... spleen, testis, ovary, muscle, and stomach. ... involved in is exerting inhibitory activity ...
... 500 Power Supply is designed ... offers extensive programming capabilities including ... methods for you to set ... simple intuitive PowerEase interface is ...
Biology Products: